Patents Assigned to Symbios Technologies, Inc.
  • Electrochemical plasma activated aqueous chemo therapeutics
    Patent number: 11666652
    Abstract: Methods for the generation of electrochemical plasma activated aqueous chemotherapeutics (EPAAC) solutions are described. These solutions have been found to selectively reduce the proliferation of human pancreatic cancer cells, with no toxic effects for healthy cells.
    Type: Grant
    Filed: March 27, 2020
    Date of Patent: June 6, 2023
    Assignee: Symbios Technologies, Inc.
    Inventors: Brooks M. Hybertson, Jessica M. Joslin, Justin P. Bzdek, Derek C. Johnson
  • ELECTROCHEMICAL PLASMA ACTIVATED AQUEOUS CHEMOTHERAPEUTICS
    Publication number: 20200323982
    Abstract: Methods for the generation of electrochemical plasma activated aqueous chemotherapeutics (EPAAC) solutions are described. These solutions have been found to selectively reduce the proliferation of human pancreatic cancer cells, with no toxic effects for healthy cells.
    Type: Application
    Filed: March 27, 2020
    Publication date: October 15, 2020
    Applicant: Symbios Technologies, Inc.
    Inventors: Brooks M. Hybertson, Jessica M. Joslin, Justin P. Bzdek, Derek C. Johnson
  • Electrochemical plasma activated aqueous chemotherapeutics
    Patent number: 10610590
    Abstract: Methods for the generation of electrochemical plasma activated aqueous chemotherapeutics (EPAAC) solutions are described. These solutions have been found to selectively reduce the proliferation of human pancreatic cancer cells, with no toxic effects for healthy cells.
    Type: Grant
    Filed: May 2, 2017
    Date of Patent: April 7, 2020
    Assignee: Symbios Technologies, Inc.
    Inventors: Brooks M. Hybertson, Jessica M. Joslin, Justin P. Bzdek, Derek C. Johnson
  • ELECTROCHEMICAL PLASMA ACTIVATED AQUEOUS CHEMOTHERAPEUTICS
    Publication number: 20170312362
    Abstract: Methods for the generation of electrochemical plasma activated aqueous chemotherapeutics (EPAAC) solutions are described. These solutions have been found to selectively reduce the proliferation of human pancreatic cancer cells, with no toxic effects for healthy cells.
    Type: Application
    Filed: May 2, 2017
    Publication date: November 2, 2017
    Applicant: Symbios Technologies, Inc.
    Inventors: Brooks M. Hybertson, Jessica M. Joslin, Justin P. Bzdek, Derek C. Johnson
  • Tubular high-density plasma reactor, with outer treatment chamber and collinear rotatable inner cylinder
    Patent number: 9346691
    Abstract: An apparatus and method for simultaneously removing materials from fluids without the need for added chemicals, and without the formation of toxic byproducts, by high-density plasma reaction chemistry is described. Applications to removal of contaminants, such as pesticides, organics, PPCPs, and pathogens, as examples, from water are discussed. Changes in the quality of the raw water are not expected to adversely affect the decontamination process.
    Type: Grant
    Filed: May 13, 2011
    Date of Patent: May 24, 2016
    Assignee: Symbios Technologies, Inc.
    Inventor: Derek C. Johnson